» Articles » PMID: 31102644

Impact of Moderate Versus Deep Sedation on Adenoma Detection Rate in Index Average-risk Screening Colonoscopies

Overview
Date 2019 May 19
PMID 31102644
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: The debate between moderate sedation versus deep sedation for index average-risk screening colonoscopies is well known to gastroenterologists. Ensuring the best of all metrics to perform quality colonoscopies for colon cancer prevention is paramount for both patients and physicians alike, because colon cancer remains the leading cause of cancer death and is the most-used screening tool in the United States. The aim of this study was to determine if moderate sedation versus deep sedation affects outcomes of adenoma detection rate (ADR) or polyp detection rate (PDR) in index, average-risk colonoscopies for colon cancer screening.

Methods: A retrospective, single, tertiary care outpatient center study of 585 healthy average-risk patients who underwent index screening colonoscopy between June 1, 2015 to December 31, 2015 (moderate sedation only) and June 1, 2016,to December 31, 2016 (deep sedation only) was performed after Institutional Review Board approval. Demographic data and polyp details were collected to determine ADR and PDR. Patients who were not average risk were excluded from the study.

Results: A total of 585 index average-risk screening colonoscopies were included in this study with 57.7% moderate sedation and 42.2% deep sedation. Neither ADR nor PDR was significantly different between the 2 groups (44.1% vs 38.5% [P = .18] and 71.9% vs 67.6% [P = .27], respectively).

Conclusions: In index average-risk screening colonoscopies, deep sedation appears to have no benefit compared with moderate sedation for ADR and PDR.

Citing Articles

Effect of anesthesia assistance on the detection rate of precancerous lesions and early esophageal squamous cell cancer in esophagogastroduodenoscopy screening: A retrospective study based on propensity score matching.

Liang M, Xu C, Zhang X, Zhang Z, Cao J Front Med (Lausanne). 2023; 10:1039979.

PMID: 37035346 PMC: 10078984. DOI: 10.3389/fmed.2023.1039979.


Adding Low-Dose Propofol to Limit Anxiety during Target-Controlled Infusion of Remifentanil for Gastrointestinal Endoscopy: Respiratory Issues and Safety Recommendations.

Motamed C, Servin F, Billard V Medicina (Kaunas). 2022; 58(9).

PMID: 36143961 PMC: 9502783. DOI: 10.3390/medicina58091285.


The Impact of Sedation on Adenoma Detection Rate and Cecal Intubation Rate in Colonoscopy.

Zhang Q, Dong Z, Jiang Y, Zhan T, Wang J, Xu S Gastroenterol Res Pract. 2020; 2020:3089094.

PMID: 33381166 PMC: 7758148. DOI: 10.1155/2020/3089094.


Impact of Moderate versus Deep Sedation and Trainee Participation on Adenoma Detection Rate-Analysis of a Veteran Population.

Marella H, Saleem N, Tombazzi C Clin Endosc. 2020; 54(2):250-255.

PMID: 33317225 PMC: 8039744. DOI: 10.5946/ce.2020.091.


Impact of propofol sedation versus opioid/benzodiazepine sedation on colonoscopy outcomes: a systematic review with meta-analysis.

Aziz M, Weissman S, Fatima R, Khan Z, Mohan B, Mehta T Endosc Int Open. 2020; 8(6):E701-E707.

PMID: 32490152 PMC: 7247890. DOI: 10.1055/a-1135-8681.